Meta facebook tracking pixel
Subscribe to these results:

Upcoming Workshops

For Breast Cancer

  1. Oct11
    Metastatic Breast Cancer: Treatment Updates
    Tags:
    breast cancermetastatic breast cancertriple negative breast cancerbiomarkerschemotherapyclinical trialsdiagnostic testsimmunotherapymastectomypersonalized medicineside effectstargeted treatmentstreatmentcoping
    Register
  2. Dec13
    Living with Breast Cancer - 46th Annual San Antonio Breast Cancer Symposium
    Tags:
    breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
    Register
  3. Jan10
    The Benefits of Clinical Trials for Triple Negative Breast Cancer
    Tags:
    breast cancermetastatic breast cancertriple negative breast cancerclinical trialstargeted treatmentstreatment
    Register
  4. Jan17
    Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)
    Tags:
    breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
    Register

For Mantle Cell Lymphoma

  1. Dec14
    Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    Tags:
    acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    Register

Past workshops

For All Cancers

    1. Clinical Trials: How They Transform the Treatment of Cancer
      Tags:
      adherenceclinical trialstargeted treatmentstreatmentbiosimilars
    2. Clinical Trials: How They Transform the Treatment of Cancer
      Tags:
      clinical trialstreatmentadherencebiosimilarspersonalized medicinetargeted treatments
    3. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      immunotherapytreatmentside effectstargeted treatmentsclinical trialsgenomicspersonalized medicine
    4. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      immunotherapytreatmentbiomarkersgenomicspersonalized medicineclinical trialsside effects
    5. Clinical Trials: How They Transform the Treatment of Cancer
      Tags:
      clinical trialsadherencebiosimilarscar t-cell therapychemotherapyimmunotherapypersonalized medicinetargeted treatments
    6. Update on Clinical Trials: How They Work
      Tags:
      clinical trials

For Acute Lymphoblastic Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Acute Myeloid Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Tags:
      basal cell cancerskin cancersquamous cell cancertreatmentclinical trials

For Bladder Cancer

    1. Bladder Cancer: Treatment Updates
      Tags:
      bladder cancertreatmentclinical trialsdiagnostic testsimmunotherapypersonalized medicinetargeted treatments
    2. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer
      Tags:
      bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments
    3. Bladder Cancer: Treatment UpdatesPart I of Life with Bladder Cancer
      Tags:
      bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments

For Bone Cancer

    1. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
      Tags:
      multiple myelomabone cancerbone marrow transplantclinical trialstargeted treatmentstreatmentbone health
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials

For Brain Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Breast Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerblack or african americanhealth care disparitiesbiomarkersclinical trialsdiagnostic testsgeneticstreatment
    5. The Benefits of Clinical Trials for Triple Negative Breast Cancer
      Tags:
      breast cancertriple negative breast cancerclinical trialstargeted treatmentstreatment
    6. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
      Tags:
      metastatic breast cancertriple negative breast cancerbreast cancerclinical trialsblack or african americanhealth care disparitiesbiomarkersdiagnostic testsside effectstargeted treatmentstreatment
    7. Metastatic Breast Cancer: Treatment Updates
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerbiomarkerschemotherapyclinical trialsdiagnostic testsimmunotherapymastectomypersonalized medicineside effectstargeted treatmentstreatment
    8. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceradherencebiosimilarscar t-cell therapychemotherapyclinical trialsimmunotherapymastectomytargeted treatmentstreatmentbiomarkersdiagnostic testsgeneticsside effects
    9. The Role of Radiation Therapy in the Treatment of Breast Cancer
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialspersonalized medicineside effectstargeted treatmentstreatment
    10. The Benefits of Clinical Trials for Triple Negative Breast Cancer
      Tags:
      breast cancertriple negative breast cancermetastatic breast cancerclinical trialshealth care disparities
    11. HER2-Positive Metastatic Breast Cancer: New Therapies
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialstreatment
    12. Metastatic Breast Cancer: Treatment Updates
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerchemotherapyclinical trialsimmunotherapymastectomypersonalized medicinetargeted treatmentstreatmentbiomarkersdiagnostic testsside effects
    13. The Benefits of Clinical Trials for Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancerclinical trials

For Chronic Lymphocytic Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    3. Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
      Tags:
      chronic lymphocytic leukemialeukemiatreatmentclinical trials
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Chronic Myelogenous Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Colorectal Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Advances in the Treatment of Colorectal Cancer
      Tags:
      colorectal canceradherencebiomarkerschemotherapyclinical trialshealth care disparitiesimmunotherapypersonalized medicinetargeted treatmentstreatmentgeneticsgenomicsdiagnostic tests
    3. Colorectal Cancer Treatment: Progress and Advances
      Tags:
      colorectal canceradherencebiomarkerschemotherapyclinical trialsimmunotherapypersonalized medicineside effectstargeted treatmentstreatment
    4. Colorectal Cancer Treatment: Progress & Advances
      Tags:
      colorectal cancertreatmentbiomarkersdiagnostic testsgeneticsgenomicsimmunotherapypersonalized medicinetargeted treatmentsclinical trials
    5. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
      Tags:
      leukemialung cancerlymphomamelanomamyelodysplastic syndromespancreatic cancermyeloproliferative neoplasmscolorectal cancerclinical trialshealth care disparitiestreatmentcoronavirus

For Cutaneous T-Cell Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Diffuse Large B-Cell Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
      Tags:
      diffuse large b-cell lymphomalymphomatreatmentclinical trialscoronavirusside effects
    8. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Follicular Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Head and Neck Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities
    2. Oral, Head and Neck Cancer: Treatment Updates
      Tags:
      head and neck canceradherencechemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatmentstreatment
    3. Oral, Head & Neck Cancer: Treatment Update
      Tags:
      head and neck canceradherencechemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatmentstreatment

For Hodgkin Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    3. Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
      Tags:
      chronic lymphocytic leukemialeukemiatreatmentclinical trials
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
    5. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
      Tags:
      leukemialung cancerlymphomamelanomamyelodysplastic syndromespancreatic cancermyeloproliferative neoplasmscolorectal cancerclinical trialshealth care disparitiestreatmentcoronavirus

For Liver Cancer

    1. Liver Cancer: Treatment Update
      Tags:
      liver canceradherencebiosimilarscar t-cell therapychemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatmentstreatment
    2. Liver Cancer: Treatment Updates
      Tags:
      liver canceradherencebiosimilarscar t-cell therapychemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatmentstreatment
    3. Liver Cancer: Treatment Updates
      Tags:
      liver cancertreatmentadherencebiosimilarscar t-cell therapychemotherapyimmunotherapypersonalized medicinetargeted treatmentsclinical trials

For Lung Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Update on Small Cell Lung CancerPart I of Living with Small Cell Lung Cancer
      Tags:
      lung cancertreatmentclinical trialscoronavirusside effects
    3. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    4. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    5. What’s New in Diagnostic Technologies for People Living with Small Cell Lung CancerPart II of Living with Small Cell Lung Cancer
      Tags:
      lung cancerdiagnostic testspersonalized medicinetargeted treatmentschemotherapyclinical trialsside effects
    6. Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
      Tags:
      lung cancerbiomarkersclinical trialsgenomicspersonalized medicinetargeted treatmentstreatment
    7. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
      Tags:
      leukemialung cancerlymphomamelanomamyelodysplastic syndromespancreatic cancermyeloproliferative neoplasmscolorectal cancerclinical trialshealth care disparitiestreatmentcoronavirus

For Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
      Tags:
      diffuse large b-cell lymphomalymphomatreatmentclinical trialscoronavirusside effects
    8. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
    9. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
      Tags:
      leukemialung cancerlymphomamelanomamyelodysplastic syndromespancreatic cancermyeloproliferative neoplasmscolorectal cancerclinical trialshealth care disparitiestreatmentcoronavirus

For Mantle Cell Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Marginal Zone Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Melanoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
      Tags:
      leukemialung cancerlymphomamelanomamyelodysplastic syndromespancreatic cancermyeloproliferative neoplasmscolorectal cancerclinical trialshealth care disparitiestreatmentcoronavirus

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options
      Tags:
      mesotheliomaadherencebiomarkerschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatmentstreatment
    2. Mesothelioma: Innovative Treatment Options
      Tags:
      mesotheliomaadherencebiomarkerschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatmentstreatment
    3. Mesothelioma: Innovative Treatment Options
      Tags:
      mesotheliomatreatmentchemotherapyimmunotherapypersonalized medicinetargeted treatmentsside effectsclinical trialsdoctor-patient communication

For Metastatic Breast Cancer

    1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    3. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerblack or african americanhealth care disparitiesbiomarkersclinical trialsdiagnostic testsgeneticstreatment
    4. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
      Tags:
      metastatic breast cancertriple negative breast cancerbreast cancerclinical trialsblack or african americanhealth care disparitiesbiomarkersdiagnostic testsside effectstargeted treatmentstreatment
    5. Metastatic Breast Cancer: Treatment Updates
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerbiomarkerschemotherapyclinical trialsdiagnostic testsimmunotherapymastectomypersonalized medicineside effectstargeted treatmentstreatment
    6. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceradherencebiosimilarscar t-cell therapychemotherapyclinical trialsimmunotherapymastectomytargeted treatmentstreatmentbiomarkersdiagnostic testsgeneticsside effects
    7. The Role of Radiation Therapy in the Treatment of Breast Cancer
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialspersonalized medicineside effectstargeted treatmentstreatment
    8. The Benefits of Clinical Trials for Triple Negative Breast Cancer
      Tags:
      breast cancertriple negative breast cancermetastatic breast cancerclinical trialshealth care disparities
    9. HER2-Positive Metastatic Breast Cancer: New Therapies
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialstreatment
    10. Metastatic Breast Cancer: Treatment Updates
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerchemotherapyclinical trialsimmunotherapymastectomypersonalized medicinetargeted treatmentstreatmentbiomarkersdiagnostic testsside effects

For Multiple Myeloma

    1. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
      Tags:
      multiple myelomabone cancerbone marrow transplantclinical trialstargeted treatmentstreatmentbone health
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    3. Progress in the Treatment of Multiple Myeloma
      Tags:
      multiple myelomatreatmentbone marrow transplantclinical trialstargeted treatments
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    5. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
    6. Progress in the Treatment of Multiple Myeloma
      Tags:
      multiple myelomatreatmentbone marrow transplantbone healthclinical trialsdoctor-patient communicationneuropathypainside effects

For Myelodysplastic Syndromes

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
      Tags:
      leukemialung cancerlymphomamelanomamyelodysplastic syndromespancreatic cancermyeloproliferative neoplasmscolorectal cancerclinical trialshealth care disparitiestreatmentcoronavirus

For Myeloproliferative Neoplasms

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
    4. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
      Tags:
      leukemialung cancerlymphomamelanomamyelodysplastic syndromespancreatic cancermyeloproliferative neoplasmscolorectal cancerclinical trialshealth care disparitiestreatmentcoronavirus

For Non-Hodgkin Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Ovarian Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Pancreatic Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
      Tags:
      leukemialung cancerlymphomamelanomamyelodysplastic syndromespancreatic cancermyeloproliferative neoplasmscolorectal cancerclinical trialshealth care disparitiestreatmentcoronavirus

For Peripheral T-Cell Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Prostate Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Sarcoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Skin Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Tags:
      basal cell cancerskin cancersquamous cell cancertreatmentclinical trials

For Small Lymphocytic Lymphoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    5. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
    7. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Squamous Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Tags:
      basal cell cancerskin cancersquamous cell cancertreatmentclinical trials

For Triple Negative Breast Cancer

    1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
    2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
      Tags:
      breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
    3. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerblack or african americanhealth care disparitiesbiomarkersclinical trialsdiagnostic testsgeneticstreatment
    4. The Benefits of Clinical Trials for Triple Negative Breast Cancer
      Tags:
      breast cancertriple negative breast cancerclinical trialstargeted treatmentstreatment
    5. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
      Tags:
      metastatic breast cancertriple negative breast cancerbreast cancerclinical trialsblack or african americanhealth care disparitiesbiomarkersdiagnostic testsside effectstargeted treatmentstreatment
    6. Metastatic Breast Cancer: Treatment Updates
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerbiomarkerschemotherapyclinical trialsdiagnostic testsimmunotherapymastectomypersonalized medicineside effectstargeted treatmentstreatment
    7. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceradherencebiosimilarscar t-cell therapychemotherapyclinical trialsimmunotherapymastectomytargeted treatmentstreatmentbiomarkersdiagnostic testsgeneticsside effects
    8. The Role of Radiation Therapy in the Treatment of Breast Cancer
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialspersonalized medicineside effectstargeted treatmentstreatment
    9. The Benefits of Clinical Trials for Triple Negative Breast Cancer
      Tags:
      breast cancertriple negative breast cancermetastatic breast cancerclinical trialshealth care disparities
    10. HER2-Positive Metastatic Breast Cancer: New Therapies
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialstreatment
    11. Metastatic Breast Cancer: Treatment Updates
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerchemotherapyclinical trialsimmunotherapymastectomypersonalized medicinetargeted treatmentstreatmentbiomarkersdiagnostic testsside effects
    12. The Benefits of Clinical Trials for Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancerclinical trials

For Waldenstrom’s Macroglobulinemia

    1. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
      Tags:
      cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.